Literature DB >> 15659776

The vascular endothelial growth factor-induced disruption of gap junctions is relayed by an autocrine communication via ATP release in coronary capillary endothelium.

Dominique Thuringer1.   

Abstract

Little is known concerning how the coordination of Ca(2+) signaling aids in capillary endothelial cell (CEC) functions, such as microvascular permeability and angiogenesis. Previous reports support the major involvement of gap junction (GJ) channels. However, the cell-to-cell communication may not be straightforward, especially if we consider the participation of active molecules released by CEC. In this study, short-term effects of vascular endothelial growth factor (VEGF-165) were compared with those of bradykinin (BK) on gap junction coupling (GJC) and remodeling of connexin-43 (Cx43) and then analyzed for intercellular Ca(2+) signal in primary cultures of coronary CEC. Dye-coupling experiments revealed that BK or VEGF completely blocked GJC. These effects correlated with the rapid internalization of Cx43 and its tyrosine phosphorylation in part via the phosphatidylinositol 3-kinase/Akt pathway. GJC slowly recovered with BK but not with VEGF in the following hour. In control conditions, mechanical stimulation of a single cell within a confluent monolayer triggered an intercellular Ca(2+) wave that was partially inhibited by GJC blockers or purinergic inhibitors. No wave propagation was observed after blockage of both GJC and purinergic receptors. Cell treatment with VEGF also reduced propagation of the Ca(2+) wave, which was totally prevented by applying a purinergic receptor antagonist but not with a GJC blocker. That excludes purine efflux through Cx hemichannels. We conclude that VEGF-induced disruption of GJC via Cx43 remodeling is relayed by an autocrine communication via secretion of ATP to preserve intercellular Ca(2+) signaling in capillary endothelium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15659776     DOI: 10.1196/annals.1329.003

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

Review 1.  Roles of gap junctions and connexins in non-neoplastic pathological processes in which cell proliferation is involved.

Authors:  Maria Lúcia Zaidan Dagli; Francisco Javier Hernandez-Blazquez
Journal:  J Membr Biol       Date:  2007-07-25       Impact factor: 1.843

Review 2.  Connexin Channels at the Glio-Vascular Interface: Gatekeepers of the Brain.

Authors:  Marijke De Bock; Luc Leybaert; Christian Giaume
Journal:  Neurochem Res       Date:  2017-06-20       Impact factor: 3.996

Review 3.  The Role of Connexin in Ophthalmic Neovascularization and the Interaction between Connexin and Proangiogenic Factors.

Authors:  Chuyang Xu; Hong Zhang; Wei Zhong; Hongyan Zhou
Journal:  J Ophthalmol       Date:  2022-06-22       Impact factor: 1.974

4.  Oncogenic extracellular HSP70 disrupts the gap-junctional coupling between capillary cells.

Authors:  Dominique Thuringer; Kevin Berthenet; Laurent Cronier; Gaetan Jego; Eric Solary; Carmen Garrido
Journal:  Oncotarget       Date:  2015-04-30

5.  Connexin43 phosphorylation by PKC and MAPK signals VEGF-mediated gap junction internalization.

Authors:  Wutigri Nimlamool; Rachael M Kells Andrews; Matthias M Falk
Journal:  Mol Biol Cell       Date:  2015-06-10       Impact factor: 4.138

6.  Increased expression of connexin 43 in a mouse model of spinal motoneuronal loss.

Authors:  Federica Maria Spitale; Nunzio Vicario; Michelino Di Rosa; Daniele Tibullo; Michele Vecchio; Rosario Gulino; Rosalba Parenti
Journal:  Aging (Albany NY)       Date:  2020-06-24       Impact factor: 5.682

7.  Electrotonic transmission in the retinal vasculature: inhibitory role of the diabetes/VEGF/aPKC pathway.

Authors:  Maho Shibata; Atsuko Nakaizumi; Donald G Puro
Journal:  Physiol Rep       Date:  2019-05

8.  MicroRNAs show mutually exclusive expression patterns in the brain of adult male rats.

Authors:  Line Olsen; Mikkel Klausen; Lone Helboe; Finn Cilius Nielsen; Thomas Werge
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.